General
Preferred name
Metamizole sodium hydrate
Synonyms
Metamizole (sodium hydrate) ()
Dipyrone (hydrate) ()
Methamizole (sodium hydrate) ()
Dipyrone sodium hydrate ()
DIPYRONE ()
Metamizol ()
Diprofarn ()
Metamizole sodium monohydrate ()
Metamizole sodium (anhydrous) ()
Metamizolum natricum anhydricum ()
Metamizol monohydrate ()
Sulpyrine hydrate ()
Metamizole sodique ()
NSC-758445 ()
Novalgin ()
Sulpyrine ()
Metamizol de sodio ()
Noramidopyrine Methanesulfonate Sodium ()
Novaldin ()
NSC-73205 ()
Analgin ()
Dipyrone anhydrous ()
Methampyrone ()
Metamizole Sodium ()
Dipyrone ()
P&D ID
PD052340
CAS
5907-38-0
Tags
available
drug
Drug Status
approved
withdrawn
Max Phase
4.0
Drug indication
Pain
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE 29
DESCRIPTION Metamizole sodium hydrate (Analgin) is a potent analgesic drug that has been demonstrated to inhibit cyclooxygenase (COX). Target: COX Dipyrone is a potent analgesic and antipyretic drug that has been used clinically for more than 80 years.
Compound Sets
4
ChEMBL Approved Drugs
ChEMBL Drugs
MedChem Express Bioactive Compound Library
Selleckchem Bioactive Compound Library
External IDs
17
Properties
(calculated by RDKit )
Molecular Weight
351.09
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
0
Rotatable Bonds
4
Ring Count
2
Aromatic Ring Count
2
cLogP
-3.4
TPSA
118.87
Fraction CSP3
0.31
Chiral centers
0.0
Largest ring
6.0
QED
0.42
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Apoptosis
COX
Pathway
Immunology/Inflammation
Source data